Risankizumab in Severe Asthma: A Phase IIa, Placebo-Controlled Study

Christopher E Brightling, Parameswaran Nair, David J. Cousins, Renaud Louis, Dave Singh

Division of Immunology, Immunity to Infection and Respiratory Medicine

University of Leicester

Research output: Contribution to journal › Article › peer-review

Immunology and Microbiology